Akari Therapeutics, Plc (AKTX) Capital expenditures 2016–2023
Akari Therapeutics, Plc (AKTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2023 · since FY2016: $54,750 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $142,249 | — |
| FY2019 | $0 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $36,885 | -32.6% |
| FY2016 | $54,750 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice